Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-22

Clinical Trial Update: Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study assessing losartan versus placebo on aortic root dilatation in Marfan syndrome patients already on beta-blockers has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan (losartan)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Marfan Syndrome | Phase 3 | Status: COMPLETED